Mar 20, 2020
US FDA issues complete response letter for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes
Mar 11, 2020
Information Update - Certain Metformin diabetes drugs recalled due to the presence or possible presence of NDMA
Mar 09, 2020
FDA Proposes Broad Approach for Conducting Safety Trials for Type 2 Diabetes Medications
Feb 05, 2020
Information Update - Apotex Inc. recalls certain lots of the diabetes medication APO-Metformin ER (extended release) 500 mg tablets
Nov 17, 2019
Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
Nov 13, 2019
Boehringer Ingelheim and Lilly announce outcome of FDA Advisory Committee meeting for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes
Sep 20, 2019
FDA approves Rybelsus® (semaglutide), the first GLP-1 analog treatment available in a pill for adults with type 2 diabetes
Jun 18, 2019
Oramed Provides Clinical Update with Meaningful Data Expected by Year-End
Jun 11, 2019
Oral Semaglutide Reduces Occurrence of Major Cardiac Events in People with Type 2 Diabetes With High Cardiovascular Risk
Jun 10, 2019
Sihuan's Abstracts regarding Clinical Trial Progress of SGLT-2 Inhibitor Selected for Poster Presentation at the American Diabetes Association's Scientific Sessions
Jun 08, 2019
Lilly's tirzepatide demonstrates benefits in data presented at the American Diabetes Association's® 79 Scientific Sessions®
Jun 04, 2019
U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes
May 22, 2019
Novo Nordisk to present data on oral semaglutide at the 79th Annual American Diabetes Association Scientific Sessions
Mar 21, 2019
North America Glucagon like Peptide - 1 Agonists Market 2019-2024 by Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide) & Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
Jan 22, 2019
Oramed Initiates Phase I Oral GLP-1 Study Under IND
Dec 04, 2018
China Glimepiride Market Report, 2013-2022 - Focus on the Third-Generation Sulfonylurea Insulin Secretagogue
Nov 13, 2018
Mordor Intelligence, LLP. Contributes to the Diabetes Awareness Month by Granting Free Access to Their Real-Time Exhaustive Research on Diabetes Care Drugs
Oct 04, 2018
Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes
Oct 04, 2018
Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes
Aug 09, 2018
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes